| RS1725521831 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1725528788 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1725580167 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS1725580228 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS1725580386 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725671086 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1725671165 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725675795 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1725679096 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS1725679318 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1725682836 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1725702758 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725743022 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1725821400 |
CP
|
Health Risk |
Pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS1725826321 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725827570 |
MTTP
|
Health Risk |
Pathogenic/Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725827762 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1725885571 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725886004 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725943334 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1725952378 |
MTTP
|
Health Risk |
Pathogenic/Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725953201 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725955180 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS1725958418 |
SLC4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive proximal renal tubular acidosis, Autosomal recessive proximal renal tubular acidosis |
| RS1725961307 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS1725996321 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1726001209 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1726024963 |
RARS2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1726067442 |
BBS7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Bardet-Biedl syndrome 7 |
| RS17261572 |
C1GALT1C1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyagglutinable erythrocyte syndrome, C1GALT1C1-related disorder |
| RS1726157542 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS1726166189 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1726209700 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS1726221197 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1726226920 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Inborn genetic diseases |
| RS1726227364 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1726229033 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS1726231891 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Inborn genetic diseases |
| RS1726233533 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS1726238223 |
PROM1
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 2, Cone-rod dystrophy 2 |
| RS1726245372 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1726246959 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, Polycystic kidney disease 2 |
| RS1726249249 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1726258048 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS1726266741 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1726269709 |
MTTP
|
Health Risk |
Pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1726363887 |
SEC24D
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1726439532 |
SEC24D
|
Health Risk |
Likely pathogenic |
Cole-Carpenter syndrome 2, Cole-Carpenter syndrome 2 |
| RS1726566546 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1726628642 |
PPP3CA
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 91, Developmental and epileptic encephalopathy 91 |
| RS1726649573 |
ANKRD17
|
Health Risk |
Pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS1726673986 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, PKD2-related disorder |
| RS1726676402 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease 2 |
| RS1726676630 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1726677278 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1726787605 |
PIGG
|
Health Risk |
Likely pathogenic |
— |
| RS1726803653 |
PPP3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS1726823468 |
PIGG
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1726841476 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1726871489 |
NDNF
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 25 with anosmia, Hypogonadotropic hypogonadism 25 with anosmia |
| RS1726901153 |
NDNF
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 25 with anosmia, Hypogonadotropic hypogonadism 25 with anosmia |
| RS1726909627 |
NSD2
|
Health Risk |
Likely pathogenic |
Rauch-Steindl syndrome, Rauch-Steindl syndrome |
| RS1726914026 |
GRID2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1726969482 |
EXOSC9
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 1D |
| RS1726987563 |
BBS7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1727004803 |
PPP3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 91, Developmental and epileptic encephalopathy 91 |
| RS1727077385 |
NDNF
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 25 with anosmia, Hypogonadotropic hypogonadism 25 with anosmia |
| RS1727086844 |
KCNH2
|
Health Risk |
Likely pathogenic |
— |
| RS1727094027 |
DOK7
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS1727096342 |
DOK7
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS1727176227 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1727323495 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1727324181 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1727326556 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1727333486 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, PKD2-related disorder |
| RS1727333593 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease 2 |
| RS1727334508 |
RSRC1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Intellectual developmental disorder |
| RS1727369694 |
CP
|
Health Risk |
Pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS1727380246 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS1727380420 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1727393873 |
FRAS1
|
Health Risk |
Likely pathogenic |
FRAS1-related disorder, FRAS1-related disorder |
| RS1727394990 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1727399068 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1727403682 |
FRAS1
|
Health Risk |
Likely pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1727412388 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1727412539 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1727413505 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1727413597 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1727420867 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, Inborn genetic diseases |
| RS1727421192 |
PKD2
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1727423812 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1727490024 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1727514792 |
CFI
|
Health Risk |
Likely pathogenic |
— |
| RS1727568821 |
SEC24D
|
Health Risk |
Likely pathogenic |
— |
| RS1727571378 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 2, Van Maldergem syndrome 2 |
| RS1727648258 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS1727649413 |
PKD2
|
Health Risk |
Pathogenic |
— |
| RS1727650877 |
PKD2
|
Health Risk |
Likely pathogenic |
— |
| RS1727651995 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1727720677 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |